Capex / revenue moved 272 bp lower
Capex / revenue changed -272 basis points from the comparable as-filed period.
6.66%→3.93%2 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →DXCM financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Free-cash-flow margin moved 2763 bp lower
Free-cash-flow margin changed -2763 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
47.91%→20.28%2 prior comparisons
Operating cash-flow margin moved 3035 bp lower
Operating cash-flow margin changed -3035 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
54.57%→24.22%2 prior comparisons
Operating cash flow / net income decreased 49.1%
Operating cash flow / net income changed -49.1% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
2.33→1.182 prior comparisons
Revenue increased 11.2%
Revenue changed +11.2% from the comparable as-filed period.
$1.2B→$1.3B2 prior comparisons
Gross profit increased 18.2%
Gross profit changed +18.2% from the comparable as-filed period.
$731.4M→$864.4M2 prior comparisons
Working capital decreased 11.7%
Working capital changed -11.7% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
$1.9B→$1.7B4 prior comparisons
Receivables / revenue moved 353 bp lower
Receivables / revenue changed -353 basis points from the comparable as-filed period.
91.76%→88.23%2 prior comparisons
Trade receivables increased 6.9%
Trade receivables changed +6.9% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
$1.1B→$1.2B4 prior comparisons
Selling, general & administrative increased 13.3%
Selling, general & administrative changed +13.3% from the comparable as-filed period.
$331.4M→$375.6M2 prior comparisons
Net income decreased 3.1%
Net income changed -3.1% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$283.8M→$275.1M2 prior comparisons
Working capital / assets moved 155 bp higher
Working capital / assets changed +155 basis points from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
25.11%→26.66%4 prior comparisons
SBC / revenue moved 99 bp lower
SBC / revenue changed -99 basis points from the comparable as-filed period.
3.73%→2.74%2 prior comparisons
Stock-based compensation decreased 18.4%
Stock-based compensation changed -18.4% from the comparable as-filed period.
$45.1M→$36.8M2 prior comparisons
Current ratio increased 11.1%
Current ratio changed +11.1% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
1.56→1.744 prior comparisons
R&D / revenue moved 100 bp lower
R&D / revenue changed -100 basis points from the comparable as-filed period.
13.02%→12.02%2 prior comparisons
Research & development increased 2.6%
Research & development changed +2.6% from the comparable as-filed period.
$157.5M→$161.6M2 prior comparisons
Cost of revenue increased 0.5%
Cost of revenue changed +0.5% from the comparable as-filed period.
$477.9M→$480.1M2 prior comparisons
Revenue increased 13.1%
Revenue changed +13.1% from the comparable as-filed period.
$1.2B→$1.3B2 prior comparisons
Free-cash-flow margin moved 395 bp lower
Free-cash-flow margin changed -395 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
18.05%→14.10%2 prior comparisons
Operating cash-flow margin moved 561 bp lower
Operating cash-flow margin changed -561 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
26.19%→20.57%2 prior comparisons
Operating cash flow / net income decreased 35.9%
Operating cash flow / net income changed -35.9% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
1.69→1.082 prior comparisons
Gross profit increased 20.5%
Gross profit changed +20.5% from the comparable as-filed period.
$688.8M→$830.0M2 prior comparisons
Working capital / assets moved 329 bp higher
Working capital / assets changed +329 basis points from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
23.50%→26.78%4 prior comparisons
Capex / revenue moved 166 bp lower
Capex / revenue changed -166 basis points from the comparable as-filed period.
8.13%→6.47%2 prior comparisons
Trade receivables decreased 6.8%
Trade receivables changed -6.8% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
$1.3B→$1.3B4 prior comparisons
Receivables / revenue moved 2044 bp lower
Receivables / revenue changed -2044 basis points from the comparable as-filed period.
116.57%→96.13%2 prior comparisons
Cash & equivalents decreased 4.7%
Cash & equivalents changed -4.7% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$1.2B→$1.1B2 prior comparisons
SBC / revenue moved 93 bp lower
SBC / revenue changed -93 basis points from the comparable as-filed period.
3.91%→2.98%2 prior comparisons
Selling, general & administrative increased 9.4%
Selling, general & administrative changed +9.4% from the comparable as-filed period.
$328.0M→$358.7M2 prior comparisons
Current ratio increased 14.0%
Current ratio changed +14.0% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
1.52→1.734 prior comparisons
R&D / revenue moved 111 bp lower
R&D / revenue changed -111 basis points from the comparable as-filed period.
12.81%→11.69%2 prior comparisons
Stock-based compensation decreased 13.9%
Stock-based compensation changed -13.9% from the comparable as-filed period.
$45.3M→$39.0M2 prior comparisons
Research & development increased 3.2%
Research & development changed +3.2% from the comparable as-filed period.
$148.2M→$153.0M2 prior comparisons
Capital expenditure decreased 10.0%
Capital expenditure changed -10.0% from the comparable as-filed period.
$94.1M→$84.7M3 prior comparisons
Cost of revenue increased 2.2%
Cost of revenue changed +2.2% from the comparable as-filed period.
$468.3M→$478.4M2 prior comparisons
Working capital increased 0.4%
Working capital changed +0.4% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$1.7B→$1.7B4 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.